Steve Laflin
Vermogen: 895 069 $ op 31-07-2026
Vermogen: 895 069 $ op 31-07-2026
Steve T.
Laflin is Chief Executive Officer at RadQual LLC since 2021.
Mr. Laflin is Director at Radnostix, Inc. since 2023.
Mr. Laflin was President & Chief Executive Officer at International Isotopes Idaho, Inc. from 1996 to 2001.
Mr. Laflin completed undergraduate studies at Idaho State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RADNOSTIX, INC. 2,42% | 26-05-2026 | 12.786.700 ( 2,42% ) | 895 069 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RADNOSTIX, INC. | Directeur/Bestuurslid | 01-06-2001 |
RadQual LLC
RadQual LLC Medical SpecialtiesHealth Technology Manufactures quality control products for the nuclear medicine and PET imaging communities | Algemeen Directeur | 01-07-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
International Isotopes Idaho, Inc.
International Isotopes Idaho, Inc. Pharmaceuticals: MajorHealth Technology Produces and supplies radioisotopes and brachytherapy for the treatment of cancer | Algemeen Directeur | 01-01-2001 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Radnostix, Inc.
Radnostix, Inc. Medical SpecialtiesHealth Technology Manufactures finished radiopharmaceuticals, pharmaceutical grade radiochemical, radioisotopes, brachytherapy medical devices | Health Technology |
Idaho State University
Idaho State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RadQual LLC
RadQual LLC Medical SpecialtiesHealth Technology Manufactures quality control products for the nuclear medicine and PET imaging communities | Health Technology |
International Isotopes Idaho, Inc.
International Isotopes Idaho, Inc. Pharmaceuticals: MajorHealth Technology Produces and supplies radioisotopes and brachytherapy for the treatment of cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau